| Name | Title | Contact Details |
|---|
TringApps Inc is a New York, NY-based company in the Software and Internet sector.
Enterprise Risk Management Solutions for Energy and Energy and Commodity trading companies worldwide. Award-winning ETRM / CTRM and CM solutions, that helps your business to track transactions, logistics and supply chain through the entire deal life...
Terabitz is the leader in IT, Real Estate, and CRM solutions. We help companies of all sizes transform how people connect, communicate, and collaborate. Delivering innovation-led strategy, technology, and business consulting services
Simio LLC is a privately held company that is dedicated to delivering leading edge solutions for the design, emulation, and scheduling of complex systems. A great place to ask technical questions and search other users comments is Simio Insiders: http:...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.